These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29452556)

  • 21. Controlling Pharmaceutical Costs in a Student-Run Free Clinic in a Resource-Limited Patient Setting.
    He C; Kalagara R; Chennareddy S; Rodriguez N; Vahanan M; Mohammad A; Skovran D; Meah Y
    J Community Health; 2023 Dec; 48(6):913-918. PubMed ID: 37405614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of medication-assistance programs for medically uninsured patients: one public teaching hospital's experience.
    Viale PH; Mister S
    Clin J Oncol Nurs; 2001; 5(6):247-52. PubMed ID: 11899624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient medication assistance program in a rural setting.
    Harmon GN; Lefante J; Roy W; Ashby KH; Jackson D; Barnard D; Smart A; Webber L
    Am J Health Syst Pharm; 2004 Mar; 61(6):603-7. PubMed ID: 15061432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription assistance programs: options for assisting the uninsured and underinsured.
    Turowski RC; Raskay-Bianco MM; Visconti JA
    Hosp Pharm; 1993 Oct; 28(10):948, 951-5, 958-68. PubMed ID: 10129140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic impact of ambulatory care formulary restrictions at a large county health system.
    Centeno A; Price V; Robinson N; Tomecko GW; Sedam B
    Am J Health Syst Pharm; 2013 Jul; 70(14):1238-43. PubMed ID: 23820461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of 340B prescription assistance program on healthcare use in chronic obstructive pulmonary disease.
    Taliaferro LM; Dodson S; Norton MC; Ofei-Dodoo S
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100295. PubMed ID: 37404594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilizing clinical pharmacists and a medication assistance program to improve medication access for indigent and underserved patients in primary care.
    Pickett B; Shin TR; Norton M
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100211. PubMed ID: 36582998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of children's health insurance: from New York State's CHild Health Plus to SCHIP.
    Szilagyi PG; Holl JL; Rodewald LE; Shone LP; Zwanziger J; Mukamel DB; Trafton S; Dick AW; Raubertas RF
    Pediatrics; 2000 Mar; 105(3 Suppl E):687-91. PubMed ID: 10699145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of a comprehensive pharmaceutical care program for an underserved population.
    Mascardo LA; Spading KA; Abramowitz PW
    Am J Health Syst Pharm; 2012 Jul; 69(14):1225-30. PubMed ID: 22761077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of an In-Sourced Patient Assistance Program at a Health System in West Virginia.
    Parmiter C; Cecere D; Czyzewski S; Gibson M
    Hosp Pharm; 2022 Dec; 57(6):734-736. PubMed ID: 36340630
    [No Abstract]   [Full Text] [Related]  

  • 33. A retrospective study of direct cost to patients associated with the use of oral oncology medications for the treatment of multiple myeloma.
    Lee C; Grigorian M; Nolan R; Binder G; Rice G
    J Med Econ; 2016; 19(4):397-402. PubMed ID: 26652728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demystifying pharmaceutical patient assistance programs.
    Collier EK; Price KN; Hsiao JL; Shi VY
    J Dermatolog Treat; 2022 Feb; 33(1):336-341. PubMed ID: 32308069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The community safety net and prescription drug access for low-income, uninsured people.
    Felland LE; Taylor EF; Gerland AM
    Issue Brief Cent Stud Health Syst Change; 2006 Apr; (105):1-4. PubMed ID: 16685778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Patient Assistance Programs on Hospital Visits in Patients With Chronic Obstructive Pulmonary Disease or Asthma.
    Gallman BN; Huddleston JW; Ray ME; Smith SE
    J Pharm Pract; 2023 Oct; 36(5):1113-1117. PubMed ID: 35428409
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
    Hamblin S; Rumbaugh K; Miller R
    J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacy assistance programs in a community health center setting.
    Torres MC; Herman D; Montano S; Love L
    J Natl Med Assoc; 2002 Dec; 94(12):1077-86. PubMed ID: 12510707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Access to Hepatitis C Treatment Using Clinical Pharmacist Services in an Uninsured, At-Risk Population at a Community Health Center.
    Fitzgerald LS; Johnston BE; Patel B; Stillwell T
    J Health Care Poor Underserved; 2021; 32(3):1433-1443. PubMed ID: 34421041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.